$ Value
$104K
Shares
5,500
Price
$19
Filed
Mar 26
Insider
Name
Raben David
Title
Chief Medical Officer
CIK
0002034679
Roles
Transaction Details
Transaction Date
2026-03-25
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
55,286
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.55 to $19.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Raben David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-25 | BCAX | M | $21K |
| 2026-03-25 | BCAX | ▼ | $104K |
| 2026-03-25 | BCAX | M | $0 |
| 2026-03-04 | BCAX | M | $62K |
| 2026-03-04 | BCAX | ▼ | $302K |
| 2026-03-04 | BCAX | M | $0 |
| 2026-03-03 | BCAX | M | $758 |
| 2026-03-03 | BCAX | ▼ | $4K |
| 2026-03-03 | BCAX | M | $0 |
| 2026-02-02 | BCAX | A | $0 |
Other Insiders at BCAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $40.0M | — | 2026-02-26 |
|
Meisner Lara
Chief Legal Officer
|
— | — | 2026-02-02 |
|
Cohlhepp Ryan
President and COO
|
— | $984K | 2026-04-15 |
|
Hyep Ivan
Chief Financial Officer
|
— | $717K | 2026-04-21 |
|
Mazumdar Claire
Chief Executive Officer
|
— | $1.5M | 2026-04-20 |
|
Raben David
Chief Medical Officer
|
— | $306K | 2026-03-25 |